微泰医疗-B(02235)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02235 微泰医疗-B

未开盘 10-16 15:50:21

6.895

+0.095

+1.40%

最高6.960	最低6.720	成交量3.36万
今开6.800	昨收6.800	日振幅3.53%
总市值28.61亿	流通市值11.31亿	总股本4.15亿
成交额22.90万	换手率0.02%	流通股本1.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02235","market":"HK","secType":"STK","nameCN":"微泰医疗-B","latestPrice":6.895,"timestamp":1792137021823,"preClose":6.8,"halted":0,"volume":33600,"delay":0,"changeRate":0.013970588235294082,"floatShares":164000000,"shares":415000000,"eps":0.097161,"marketStatus":"未开盘","change":0.095,"latestTime":"10-16 15:50:21","open":6.8,"high":6.96,"low":6.72,"amount":228998,"amplitude":0.035294,"askPrice":6.895,"askSize":8000,"bidPrice":6.79,"bidSize":4100,"shortable":0,"etf":0,"ttmEps":0.229,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":0,"adr":0,"listingDate":1634572800000,"exchange":"SEHK","adjPreClose":6.8,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":3.962264104218584,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02235","defaultTab":"news","newsList":[{"id":"1180086267","title":"微泰医疗-B发布2026年9月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1180086267","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180086267?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:38","pubTimestamp":1791275927,"startTime":"0","endTime":"0","summary":"微泰医疗-B于2026年10月6日公布截至2026年9月30日的股份变动月报。公告显示，截至报告期末，公司法定注册股本维持在人民币421,078,000股，较上月无变化。从股本结构看，H股本月合计保持在169,175,842股不变，期间公司回购173,600股H股并将其转为库存股份。截至9月底，H股已发行股份由上月底的163,180,542股降至163,006,942股，库存股份由5,995,300股增至6,168,900股。内资股与非上市外资股分别维持在212,162,222股和39,739,936股，均未发生变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673770067","title":"【券商聚焦】中信建投维持微泰医疗（02235）买入评级 指CGM驱动业绩高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2673770067","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673770067?lang=zh_cn&edition=full","pubTime":"2026-10-05 14:39","pubTimestamp":1791182389,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券发布研报指，微泰医疗-B 2026年上半年实现收入人民币4.14亿元，同比增长68.4%；归母净利润人民币4027万元，上年同期为-229万元。收入超前瞻报告预期，主要受益于CGM在国内外销量高速增长，胰岛素泵系统国际市场销量显著增长；利润扭亏为盈，主要由于收入大幅增长、毛利率改善、费用率持续优化。维持“买入”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148325958","title":"微泰医疗-B2026年中期营收4.14亿元，经调整净利润0.40亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148325958","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148325958?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:03","pubTimestamp":1790586205,"startTime":"0","endTime":"0","summary":"2026年上半年，微泰医疗-B实现营收4.14亿元，同比增长68.4%。期内经调整净利润0.40亿元，而上年同期为亏损约0.02亿元，同比增长1856.6%。受主要产品持续放量影响，毛利达到2.39亿元，同比增长88.1%，毛利率从2025年上半年的51.7%提升至57.7%，上升了约6个百分点。期内经营活动产生的现金流量净额约为5741.03万元，相较上年同期的442.85万元增长约1196%。2026年上半年销售费用为1.18亿元，同比增加约27.1%，但因营收基数大幅上升，销售费用率由37.7%下降至28.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"微泰医疗-B2026年中期营收4.14亿元，经调整净利润0.40亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167114206","title":"微泰医疗-B：2026年9月15日回购300股，涉资2,010港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167114206","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167114206?lang=zh_cn&edition=full","pubTime":"2026-09-15 16:56","pubTimestamp":1789462570,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月15日在香港联交所回购股份，数量合计300股，占当日回购前已发行股本的约0.0002%。回购价格为每股6.70港元，合计支付金额2,010港元。本次回购的股份将以库藏股方式持有。公司于2026年6月10日获股东大会通过购回授权，授权购回股份总数为16,416,184股，截至目前已累计回购738,100股，占该授权日已发行股份总数约0.4508%。根据公告，后续任何新股发行或库藏股再出售适用的暂止期截至2026年10月15日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"微泰医疗-B：2026年9月15日回购300股，涉资2,010港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667485446","title":"微泰医疗-B(02235.HK)9月15日斥资2010港元回购300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667485446","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667485446?lang=zh_cn&edition=full","pubTime":"2026-09-15 16:55","pubTimestamp":1789462517,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178189872","title":"微泰医疗-B 9月14日回购6100股股份，斥资约4.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178189872","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178189872?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:13","pubTimestamp":1789380800,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月14日发布翌日披露报表，公布当日在香港联交所场内回购6100股普通股，占回购前已发行股本约0.0037%。本次回购每股价格介乎6.55港元至6.80港元，总金额40,477.50港元，折合约4.05万港元。根据公告，本次回购后，相关暂止期截至2026年10月14日。公告由执行董事及联席公司秘书施永辉签署，公司再次确认已遵守香港联交所上市规则及有关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B 9月14日回购6100股股份，斥资约4.05万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667575226","title":"微泰医疗-B(02235)9月14日斥资4.05万港元回购6100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667575226","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667575226?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:10","pubTimestamp":1789380616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微泰医疗-B(02235)发布公告，于2026年9月14日，该公司斥资4.05万港元回购6100股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105943106","title":"微泰医疗-B 9月11日回购20,800股股份，耗资约13.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105943106","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105943106?lang=zh_cn&edition=full","pubTime":"2026-09-11 18:25","pubTimestamp":1789122348,"startTime":"0","endTime":"0","summary":"2026年9月11日，微泰医疗器械（杭州）股份有限公司发布翌日披露报表，公告当日于香港联交所场内回购20,800股H股普通股，占公司此前一日163,034,142股已发行股份总数的约0.0128%。本次回购每股价格介乎每股6.51港元至6.70港元，总耗资138,120.50港元。公司回购授权决议于2026年6月10日获通过，可回购股份总数为16,416,184股，截至目前已在包括本交易所在内的证券交易所累计回购731,700股。公司同时确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B 9月11日回购20,800股股份，耗资约13.81万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666127155","title":"【券商聚焦】中信建投：医疗器械板块业绩有望逐步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2666127155","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666127155?lang=zh_cn&edition=full","pubTime":"2026-09-11 09:18","pubTimestamp":1789089493,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。该机构认为，随着集采影响逐步出清叠加创新驱动和海外业务加速的双重助力，医疗器械板块业绩有望逐步改善。尽管季度业绩增速可能有所波动，Q3能否相比Q2加速尚不确定，但大趋势来看，26和27年年度业绩持续改善的确定性较强。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991348","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1584","LU0173614495.USD","00241","159883","BK1100","BK1502","BK1571","01302","LNGR","LU0287142896.SGD","MEDX","MDEV","BK1615","KCE","BK1189","RSPH","AGNG","BK1589","601066","BK1142","BK1583","BK1501","BK1600","09996","02235","PTH","HK0000165453.HKD","LGHT","BK0276","BK1587","BK1591","02252","BK1574","BK1617","01066","BK1585","00853","BK1593","BK1515","02190","BK1610","GDOC","HART","BK1247","BK1222","BK1161","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666400567","title":"微泰医疗-B(02235.HK)9月10日斥资33.03万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666400567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666400567?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:53","pubTimestamp":1789037634,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147869670","title":"微泰医疗-B回购5万股股份，总额约33.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147869670","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147869670?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:52","pubTimestamp":1789037534,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月10日公告回购股份事宜。根据公告，回购于同日于香港联交所场内进行，合计购回50,000股，占当日前已发行股本0.0307%。回购价格区间介乎每股6.53港元至6.70港元，支付总金额为330,287港元。回购完成后，公司已发行股份总数保持169,175,842股，其中包括6,141,700股库藏股和163,034,142股已发行股份。截至目前，企业已根据授权累计购回710,900股，占授权通过当日已发行股本约0.4342%。本次公告由执行董事及联席公司秘书施永辉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B回购5万股股份，总额约33.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193093828","title":"微泰医疗-B：9月9日回购2.85万股，耗资约18.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193093828","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193093828?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:46","pubTimestamp":1788947202,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月9日公告回购股份。公司当日于香港联交所场内回购 H 股共计28,500股，占回购前公司已发行股本约0.0175%。本次回购的最高价格为每股6.70港元，最低价格为每股6.605港元，合计耗资189,632港元。公司同日披露，截至回购结束后，已发行股本数目为163,084,142股，库藏股数为6,091,700股，发行总股本维持在169,175,842股。公告显示，公司确认已遵守香港联合交易所有限公司证券上市规则以及相关法律与监管规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B：9月9日回购2.85万股，耗资约18.96万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581398","title":"微泰医疗-B(02235)9月9日斥资18.96万港元回购2.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666581398?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:37","pubTimestamp":1788946643,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微泰医疗-B(02235)发布公告，于2026年9月9日斥资18.96万港元回购2.85万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107521509","title":"微泰医疗-B回购4.17万股股份，总额约27.86万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107521509","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107521509?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:46","pubTimestamp":1788860785,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月8日发布公告，披露当日于香港联交所回购H股41,700股，约占回购前公司已发行股本总数的0.0256%。本次回购的每股价格介于6.60港元至6.70港元之间，总涉资约27.86万港元。本次股份购回完成后，公司已发行股本总数维持在169,175,842股，其中已发行股份数目变动为163,112,642股，库藏股数增至6,063,200股。公司此前于2026年6月10日获股东大会授权可回购最多16,416,184股，迄今已累计回购632,400股，占该授权通过当日已发行股份总数的约0.3862%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B回购4.17万股股份，总额约27.86万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319250","title":"微泰医疗-B：新一代分体式持续葡萄糖监测系统获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319250","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319250?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:30","pubTimestamp":1788780600,"startTime":"0","endTime":"0","summary":"9月7日，微泰医疗-B（02235）发布公告，近日公司新一代分体式持续葡萄糖监测系统AiDEXG9获得国家药品监督管理局的上市批准。该产品相较于第一代分体式产品实现了技术架构的创新变革，并在体积、轻便度与佩戴舒适度上全面升级，为糖尿病患者提供更轻盈、更自信的血糖管理体验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866847884.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866847884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02235","BK1100","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199865302","title":"微泰医疗-B回购26,200股股份，总额约17.46万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199865302","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199865302?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:15","pubTimestamp":1788779755,"startTime":"0","endTime":"0","summary":"微泰医疗器械（杭州）股份有限公司于2026年9月7日发布公告称，公司于当日回购26,200股普通H股，约占回购前已发行股份总数的0.0161%。本次回购股份的最高价为每股6.70港元，最低价为每股6.60港元，合计付出价款约17.46万港元。回购完成后，公司已发行股份数降至163,154,342股，库存股份增加至6,021,500股，合计股份总数保持为169,175,842股。公告显示，该次回购系根据2026年6月10日通过的股份购回授权进行，授予公司可回购最多16,416,184股的权限。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B回购26,200股股份，总额约17.46万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131981","title":"微泰医疗-B(02235)9月7日斥资17.46万港元回购2.62万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131981","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665131981?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:11","pubTimestamp":1788779509,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微泰医疗-B(02235)发布公告，于2026年9月7日斥资17.46万港元回购2.62万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319893","title":"微泰医疗-B(02235.HK)：持续葡萄糖监测系统AiDEX G9获国家药品监督管理局注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319893?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:11","pubTimestamp":1788779501,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174921206","title":"微泰医疗-B（02235）新一代CGM系统AiDEX G9获国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1174921206","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174921206?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:11","pubTimestamp":1788779487,"startTime":"0","endTime":"0","summary":"2026年9月7日，微泰医疗器械（杭州）股份有限公司公告称，其新一代分体式持续葡萄糖监测系统AiDEX G9已获得国家药品监督管理局注册批准。据公告，AiDEX G9相较公司第一代分体式产品在技术架构、体积、轻便度及佩戴舒适度等方面全面升级，旨在为糖尿病患者提供更轻盈、自在的血糖管理体验。微泰医疗-B同时提醒投资者，相关产品的生产、销售及收益仍受市场等多重因素影响，投资者在买卖公司股份时需审慎行事。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140436721","title":"微泰医疗-B（杭州）旗下Aidex G9获中国国家药品监督管理局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1140436721","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140436721?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:08","pubTimestamp":1788779294,"startTime":"0","endTime":"0","summary":"微泰医疗-B（杭州）宣布，其Aidex G9产品已正式获得中国国家药品监督管理局（NMPA）的上市批准。这一里程碑式的进展，标志着该公司在医疗器械领域的又一重要突破。Aidex G9的获批，不仅彰显了微泰医疗在技术创新与质量管控上的深厚积累，也为其进一步拓展国内市场份额奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":0.0283},{"period":"3month","weight":-0.0178},{"period":"6month","weight":-0.0916},{"period":"1year","weight":-0.0794},{"period":"ytd","weight":-0.1305}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微泰医疗器械（杭州）股份有限公司是一家主要从事医疗器械的研发、生产和销售的中国公司。该公司的主营业务是生产和销售血糖监测系统（BGMS）、持续葡萄糖监测系统（CGMS）和胰岛素泵系统。该公司在糖尿病监测、治疗、管理领域拥有产品组合，涵盖贴敷式胰岛素泵系统、持续葡萄糖监测系统、闭环人工胰腺系统、血糖监测系统以及糖尿病数字管理软件等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.189861},{"month":2,"riseRate":0.4,"avgChangeRate":-0.078129},{"month":3,"riseRate":0.4,"avgChangeRate":0.009968},{"month":4,"riseRate":0.4,"avgChangeRate":-0.003701},{"month":5,"riseRate":0,"avgChangeRate":-0.088227},{"month":6,"riseRate":0.2,"avgChangeRate":-0.027697},{"month":7,"riseRate":0.2,"avgChangeRate":0.007766},{"month":8,"riseRate":0.6,"avgChangeRate":0.002033},{"month":9,"riseRate":0.2,"avgChangeRate":-0.028452},{"month":10,"riseRate":0.2,"avgChangeRate":-0.058042},{"month":11,"riseRate":0.8,"avgChangeRate":0.034888},{"month":12,"riseRate":0.8,"avgChangeRate":0.248824}],"exchange":"SEHK","name":"微泰医疗-B","nameEN":"MICROTECH MED-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微泰医疗-B(02235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微泰医疗-B(02235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微泰医疗-B,02235,微泰医疗-B股票,微泰医疗-B股票老虎,微泰医疗-B股票老虎国际,微泰医疗-B行情,微泰医疗-B股票行情,微泰医疗-B股价,微泰医疗-B股市,微泰医疗-B股票价格,微泰医疗-B股票交易,微泰医疗-B股票购买,微泰医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微泰医疗-B(02235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微泰医疗-B(02235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}